Low histamine resistance syndrome: is it cause or result of gastrointestinal tract pathology?
https://doi.org/10.31146/1682-8658-ecg-179-7-152-157
Abstract
Currently, in the Russian Federation, as well as throughout the world, there is an increase in allergic diseases, including an increase in the number of gastrointestinal manifestations of allergies. Moreover, along with Ig-E-mediated reactions, anaphylactoid reactions occur due to the excessive release of histamine and other biologically active substances from mast cells. These pathological processes can contribute to exacerbation of functional disorders of the gastrointestinal tract, enhancing subclinical inflammation of the mucous membrane, contributing to the development of visceral hypersensitivity and gastrointestinal motility. At the same time, most medical practitioners do not pay due attention to the possible impact of allergic and pseudo-allergic reactions on the course of irritable bowel syndrome and functional dyspepsia. At the same time, it is necessary to take into account that in the case of the syndrome of low resistance to histamine in most patients, the introduction of restrictions on the diet is sufficient and there is no need to prescribe excess drugs. Given the widespread prevalence of functional disorders of the gastrointestinal tract and their significant impact on the quality of life of patients, it is necessary to search for new methods of prevention and treatment of this group of pathological conditions.
About the Authors
M. S. Turchina
Orel State University
Russian Federation
Russian Federation
Mariya S. Turchina - Associate Professor, Department of Internal Medicine.
Orel.
Z. V. Karaseva
Orel State University
Russian Federation
Russian Federation
Zoya V. Karaseva - 6 year student.
Orel.
References
1. Rosell-Camps A., Zibetti S., Perez-Esteban G., Vila-Vidal M. et al. Histamine intolerance as acause of chronic digestive complaints in pediatric patients. RevEsp Enferm Dig. 2013; 105(4): 201-207 DOI: 10.4321/s1130-01082013000400004
2. Asher M. L. The International Study of Asthma and Allergies in Childhood (ISAAC). Clin. Exp. Allergy. 1998; 28 (5): 52-66 DOI: 10.1046/j.1365-2222.1998.028s5052.x
3. Kovacova-Hanuskova E., Buday T., Gavliakova S., Plev-kova J. (2015). Histamine, histamine intoxication and intolerance. Allergologia et Immunopathologia. 2015; 43(5): 498-506 DOI: 10.1016/j.aller.2015.05.001
4. Bulatova E. M., Bogdanova N. M., Lobanova E. A., Gabrusskaya T. V. Intestinal microbiota: current views. Pediatria. 2009; 88 (3).
5. Jarisch R. (ed), Gotz M., Hemmer W., Missbichler A. et al. Histamin-Intoleranz. Histamin und Seekrankheit. -New York: Georg Thieme Verlag, 2004
6. Kanki M., Yoda T., Tsukamoto T., Baba E. Histidine decarboxylases and their role in accumulation of histamine in tuna and dried saury. Appl Environ Microbiol. 2007; 73(5): 1467-1473 DOI: 10.1128/aem.01907-06
7. Best C. H., Dale H. H., Dudley H. W., Th orpe W. V. The nature of the vaso-dilator constituents of certain tissue extracts. J Physiol. 1927;62(4): 397-417 DOI: 10.1113/jphysiol.1927.sp002369
8. AccessScience Editors. Histamine and histamine intolerance. AccessScience. McGraw-Hill Education. 2014 DOI: 10.1036/1097-8542.br10229141
9. Vlie-Boerstra B.J., Van der H. S., Oude Elberink J. N., Kluin-Nelemans J. C. Mastocytosis and adverse reactions to biogenic amines and histamine releasing foods: what is the evidence? Neth J. Med. 2005; 63(7): 244-249
10. Ring J., Kohn F. M. Fallstricke und Fehlerquellen in der Dermatologie. Allergologie. - Munich, Germany: Urban & Vogel, 2004 - P. 105-120 DOI: 10.1007/9783-7091-0577-1
11. Maintz L., Novak N. Histamine and histamine intolerance. The American Journal of Clinical Nutrition. 2007; 85(5): 1185-1196. doi:10.1093/ajcn/85.5.1185
12. Schwelberger H. G. Diamine oxidase (DAO) enzyme and gene. Histamine: biology and medical aspects. -Budapest: SpringMed Publishing, 2004, рр. 43-52
13. Schwelberger H. G. Histamine N-methyltransferase (HNMT) enzyme and gene. Histamine: biology and-medical aspects. - Budapest: SpringMed Publishing, 2004 - P. 53-59
14. Schmidt W. U., Sattler J., Hesterberg R., Roher H. D. et al. Human intestinal diamine oxidase (DAO) activity in Crohn's disease: a new marker for disease assessment? Agents Actions. 1990; 30(1-2): 267-270 DOI: 10.1093/ajcn/85.5.1185
15. Raithel M., Kufner M., Ulrich P. Hahn E. G. The involvement of the histamine degradation pathway by diamine oxidase in manifest gastrointestinal allergies. Inflamm Res. 1999; 48(0): 75-76 DOI: 10.1007/s000110050414
16. Wantke F., Hemmer W., Haglmuller T., Gotz M. et al. Histamine in wine. Bronchoconstriction after a double-blind placebo-controlled red wine provocation test. Int Arch Allergy Immunol. 1996; 97(1): 238-238 DOI: 10.1016/s0091-6749(96)80440-4
17. Zaitsev V. G., Zheltova A. A. Histamine intolerance and diamine oxidase activity: issues of virtual screening. Russian Journal of Immunology. 2016;10(19):553-554. (In Russ.)
18. Petersen J., Drasche A., Raithel M., Schwelberger, H. G. Analysis of genetic polymorphisms of enzymes involved in histamine metabolism. Inflamm Res. 2003; 52(0): 69-70 DOI: 10.1007/s000110300059
19. Schwelberger H. G., Drasche A., Petersen J., Raithel M. Genetic polymorphisms of histamine degrading enzymes: from small-scale screening to high-throughput routine testing. Inflamm Res. 2003; 52(0): 71-73 DOI: 10.1007/s000110300060
20. Petersen J., Raithel M., Schwelberger H. G. Histamine N-methyltransferase and diamine oxidase gene polymorphisms inpatients with inflammatory and neoplastic intestinal diseases. Inflamm Res. 2002; 51(1): 91-92.
21. Thurmond R. L. The histamine H4 receptors: from orphan to the clinic. Front Pharmacol. 2015; 31(6): 65 DOI: 10.3389/fphar.2015.00065
22. Siebenhaar F., Melde A., Magerl M., Zuberbier T. et al. Histamine intolerance in patients with chronic spontaneous urticaria. Journal of the European Academy of Dermatology and Venereology. 2016; 30(10): 1774-1777 DOI: 10.1111/jdv.13778
23. Alstadhaug K. B. Histamine in migraine and brain. Headache: The Journal of Head and Face Pain. 2014; 54(2): 246-259 DOI: 10.1111/head.12293
24. Jadid-Niaragh F., Mirshafi ey A. Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis. Neuropharmacology. 2010; 59(3): 180-189 DOI: 10.1016/j.neuropharm.2010.05.005
25. Steinbrecher I., Jarisch R. Histamin und Kopfschmerz. Allergologie. 2005; 28(03): 84-91 DOI: 10.5414/alp28085
26. Wantke F., Gotz M., Jarisch R. Histamine-free diet: treatment of choice for histamine-induced food intolerance and supporting treatment for chronic headaches. Clin Exp Allergy. 1993; 23(12): 982-985 DOI: 10.1111/j.1365-2222.1993.tb00287.x
27. Morel F., Surla A., Vignais P. V. Purification of human placenta diamine oxidase. Biochem Biophys Res Commun. 1992; 187(1): 178-186
28. Jarisch R., Wantke F. Wine and headache. Int Arch Allergy Immunol. 1996; 110 (1): 7-12 DOI: 10.1159/000237304
29. Kritas S. K., Saggini A., Cerulli G., Speziali A. et al. Asthma and mast cell biology. Eur J Inflamm. 2014; 12(2): 261-265 DOI: 10.1177/1721727x1401200205
30. Yan L., Galinsky R. E., Bernstein J. A., Liggett S. B. et al. Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma. Pharmacogenetics. 2000; 10(3): 261-266 DOI: 10.1097/00008571-200004000-00007
31. Bodis J., Tinneberg H. R., Schwarz, H., Papenfuss F. et al. The effect of histamine on progesterone and estradiol secretion of human granulosa cells in serum-free culture. GynecolEndocrinol. 1993; 7(4): 235-239 DOI: 10.3109/09513599309152507
32. Jarisch R. Histamine Intolerance. Histamine Intolerance in Women. - Heidelberg: Springer Verlag, 2014, рр. 109115 DOI: 10.1007/978-3-642-55447-6_6
33. Jutel M., Akdis M., Akdis C. A. Histamine, histamine receptors and their role in immune pathology. Clin Exp Allergy. 2009; 39(12): 1786-1800 DOI: 10.1111/j.1365-2222.2009.03374.x
34. Alhazzani W., Alenezi F., Jaeschke R. Z., Moayyedi P. et al. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Critical care medicine. 2013; 41(3): 693-705 DOI: 10.1097/ccm.0b013e3182758734
35. Ellenbroek B. A., Ghiabi B. The other side of the histamine H3 receptor. Trends Neurosci. 2014; 37(4): 191-195 DOI: 10.1016/j.tins.2014.02.007
36. Tabarean I. V. Histamine receptor signaling in energy homeostasis. Neuropharmacology. 2016; 106: 13-19 DOI: 10.1016/j.neuropharm.2015.04.011
37. Komericki P., Klein G., Reider N., Hawranek T. et al. Histamine intolerance: of reproducibility of single symptoms by oral provocation with histamine: a randomized, double-blind, placebo-controlled crossover study. Wien Klin Wochenschr. 2011; 123(1-2): 15-20 DOI: 10.1007/s00508-010-1506-y
38. Zampeli E., Tiligada E. The role of histamine H4 receptor in immune and inflammatory disorders. British Journal of Pharmacology. 2009; 157(1): 24-33 DOI: 10.1111/j.1476-5381.2009.00151.x
39. Thewes J., Rakoski J., Ring, M. Histamine Intolerance Imitated a Fish Allergy. Acta Dermato-Venereologica, 1999; 79(1): 89-89 DOI: 10.1080/000155599750011859
40. Visciano P., Schirone M., Tofalo R., Suzzi G. Histamine poisoning and control measures in fish and fishery products. Front Microbiol. 2014; 5: 500 DOI: 10.3389/fmicb.2014.00500
41. Schwelberger, H. G. Histamine intolerance: a metabolic disease? Inflamm Res. 2009; 59(S2): 219-221 DOI: 10.1007/s00011-009-0134-3
42. Sattler J., Lorenz W. Amine Oxidases and Their Impact on Neurobiology. Intestinal diamine oxidases and enteral-induced histaminosis: studies on three prognostic variables in an epidemiological model. - Vienna: Springer, 1990. - P. 291-314 DOI: 10.1007/978-3-7091-9113-2_39
43. Sattler J., Hesterberg R., Lorenz W., Schmidt U. et al. Inhibition of human and canine diamine oxidase by drugs used in an intensive care unit: relevance for clinical side effects? Agents Actions. 1985; 16(3-4): 91-94 DOI: 10.1007/bf01983109
44. Wantke F., Proud D., Siekierski E., Kagey-Sobotka A. Daily variations of serum diamine oxidase and the influence of H1 and H2 blockers: a critical approach to routine diamine oxidase assessment. Inflamm Res. 1998; 47(10): 396-400 DOI: 10.1007/s000110050350
45. Schwelberger H. G. Histamine intolerance: overestimated or underestimated. Inflamm Res. 2009; 58(1): 51-52 DOI: 10.1007/s00011-009-2004-4
46. Kofler L., Ulmer H., Kofler, H. Histamine 50-Skin-Prick Test: A Tool to Diagnose Histamine Intolerance. ISRN Allergy. 2011: 1-5 DOI: 10.5402/2011/353045
47. Music E., Korosec P., Silar M., Adamic K et al. Serum diamine oxidasa activity as a diagnostic test for histamine intolerance. Wien Kin Wochenschr. 2013; 125(9-10): 239-243 DOI: 10.1007/s00508-013-0354-y
48. Kohn, J. B. Is There a Diet for Histamine Intolerance? Journal of the Academy of Nutrition and Dietetics. 2014; 114(11): 1860 DOI: 10.1016/j.jand.2014.09.009
49. Colome Rivero G., Tormo Carnicer R., Rosell Camps A. et al. Diaminooxidase low levels and paediatric gastrointestinal pathology. 47Th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. 9-12 June 2014. Jerusalem, Israel.
50. San Mauro Martin I., Brachero S., Garicano Vilar E. Histamine intolerance and dietary management: A complete review. Allergologia et Immunopathologia. 2016; 44(5): 475-483 DOI: 10.1016/j.aller.2016.04.015
Review
For citations:
Turchina M.S., Karaseva Z.V. Low histamine resistance syndrome: is it cause or result of gastrointestinal tract pathology? Experimental and Clinical Gastroenterology. 2020;(7):152-157. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-179-7-152-157
Views:
700
Email this article 